Future Health ESG Corp.: Nasdaq/NYSE listing notice — Future Health ESG receives Nasdaq delisting notice; intends to appeal

Future Health ESG Corp.

Received Nasdaq notice Dec 4, 2023 for failing Minimum Public Holders Rule (≥300 holders).
Trading of common stock, units, and warrants to be suspended Dec 13, 2023 unless hearing is requested.
Company must request appeal hearing by 4:00 PM ET Dec 11, 2023 to stay suspension.
Company plans to timely request a hearing before Nasdaq Hearings Panel to appeal determination.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Future Health ESG Corp. received a nasdaq delisting notice notice regarding other (rules 5550(a)(3)).

Exchange: nasdaq
Notice: delisting notice
Rules: 5550(a)(3)

Exact text from the filing

December 4, 2023, Future Health ESG Corp. (the “Company”), received a written notice (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company has not regained compliance with Listing Rule 5550(a)(3) (the “Minimum Public Holders Rule”), which requires the Company to have at least 300 public holders for continued listing on Nasdaq, trading of the Company’s common stock will be suspended at the opening of business on December 13, 2023 and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SE

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-23-124763

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.